The effects of alprazolam on corticotropin-releasing factor neurons in the rat brain: acute time course, chronic treatment and abrupt withdrawal
- PMID: 1649300
The effects of alprazolam on corticotropin-releasing factor neurons in the rat brain: acute time course, chronic treatment and abrupt withdrawal
Abstract
Considerable evidence indicates that corticotropin-releasing factor (CRF) is responsible for integrating not only the endocrine, but the autonomic and behavioral responses of an organism to stress. We have investigated the time course of action of the anxiolytic triazolobenzodiazepine, alprazolam, on the activity of the hypothalamic-pituitary-adrenal (HPA) axis and of CRF neurons after acute and chronic administration. In addition, because many of the signs and symptoms observed in animals and humans after abrupt discontinuation of benzodiazepines resemble the stress response, we examined the effect of alprazolam withdrawal on CRF neurons and HPA axis activity. Alprazolam decreases CRF concentrations in the locus coeruleus between 0.5 and 3.0 h following acute injection. The half-life of alprazolam in rats is less than 1 h in both plasma and brain. Similarly, chronic (14 days) alprazolam administration also results in decreased CRF concentrations in the locus coeruleus. CRF concentrations return to control values 24 h after abrupt withdrawal. Moreover, abrupt alprazolam withdrawal results in increased plasma adrenocorticotrophic hormone and corticosterone concentrations and decreased anterior pituitary CRF receptor concentrations 24 h after drug discontinuation. These indices return to control values by 48 h postwithdrawal. These results support the hypothesis that both acute and chronic alprazolam administration alters CRF-containing neurons innervating the locus coeruleus. Additionally, abrupt alprazolam withdrawal profoundly activates the HPA axis.
Similar articles
-
The effects of alprazolam on corticotropin-releasing factor neurons in the rat brain: implications for a role for CRF in the pathogenesis of anxiety disorders.J Psychiatr Res. 1993;27 Suppl 1:209-20. doi: 10.1016/0022-3956(93)90029-2. J Psychiatr Res. 1993. PMID: 8145178
-
The 5-hydroxytryptamine2 agonist, (+-)-1-(2,5-dimethoxy-4-bromophenyl)-2-aminopropane stimulates the hypothalamic-pituitary-adrenal (HPA) axis. I. Acute effects on HPA axis activity and corticotropin-releasing factor-containing neurons in the rat brain.J Pharmacol Exp Ther. 1991 Feb;256(2):787-94. J Pharmacol Exp Ther. 1991. PMID: 1847212
-
Acute effects of alprazolam and adinazolam on the concentrations of corticotropin-releasing factor in the rat brain.Synapse. 1989;4(3):196-202. doi: 10.1002/syn.890040304. Synapse. 1989. PMID: 2575286
-
The role of corticotropin-releasing factor in drug addiction.Pharmacol Rev. 2001 Jun;53(2):209-43. Pharmacol Rev. 2001. PMID: 11356984 Review.
-
The role of corticotropin-releasing factor in the pathogenesis of major depression.Pharmacopsychiatry. 1988 Mar;21(2):76-82. doi: 10.1055/s-2007-1014652. Pharmacopsychiatry. 1988. PMID: 3293091 Review.
Cited by
-
The CRF1 receptor antagonist R121919 attenuates the neuroendocrine and behavioral effects of precipitated lorazepam withdrawal.Psychopharmacology (Berl). 2007 Jun;192(3):385-96. doi: 10.1007/s00213-007-0713-3. Epub 2007 Feb 13. Psychopharmacology (Berl). 2007. PMID: 17297634
-
Nicotinic activation of CRH neurons in extrahypothalamic regions of the rat brain.Endocrine. 1997 Oct;7(2):245-53. doi: 10.1007/BF02778147. Endocrine. 1997. PMID: 9549051
-
Physiological and neurochemical aspects of corticotropin-releasing factor actions in the brain: the role of the locus coeruleus.Neurochem Res. 1998 Aug;23(8):1039-52. doi: 10.1023/a:1020751817723. Neurochem Res. 1998. PMID: 9704593 Review.
-
Pharmacokinetics and bioavailability of midazolam after intravenous, subcutaneous, intraperitoneal and oral administration under a chronic food-limited regimen: relating DRL performance to pharmacokinetics.Psychopharmacology (Berl). 1996 Aug;126(3):241-8. doi: 10.1007/BF02246454. Psychopharmacology (Berl). 1996. PMID: 8876024
-
Maternal care during infancy regulates the development of neural systems mediating the expression of fearfulness in the rat.Proc Natl Acad Sci U S A. 1998 Apr 28;95(9):5335-40. doi: 10.1073/pnas.95.9.5335. Proc Natl Acad Sci U S A. 1998. PMID: 9560276 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources